Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, Cantor Fitzgerald Ink Stock Transaction Agreement

NEW YORK(GenomeWeb) – Affymetrix said on Tuesday that it has signed an agreement with Cantor Fitzgerald for the potential sale of Affymetrix's stock.

Under the terms of the deal, disclosed in a document filed with the US Securities and Exchange Commission, Affy may offer and sell its shares from time to time through the investment bank acting as Affy's agent. Any sale will be made under Affy's shelf registration filed in June 2012 to offer up to $50 million of its shares. 

The company's shares will be sold at market price or at a price agreed upon by Affy and Cantor Fitzgerald. Affy may also sell shares to Cantor Fitzgerald for its own account under terms agreed upon by the two companies. 

Affy recently noted in its third quarter report that it had $68.3 million in cash and cash equivalents as of Sept. 30.

In morning trading on Wednesday Affy's stock was down almost 4 percent on the Nasdaq at $9.22.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.